Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
Johan Maertens, Galia Rahav, Dong‐Gun Lee, Alfredo Ponce‐de‐León, Isabel Cristina Ramírez Sánchez, Н Н Климко, Anne Sonet, Shariq Haider, Juan D. Vélez, Issam Raad, Liang‐Piu Koh, Meinolf Karthaus, Jianying Zhou, Ronen Ben‐Ami, Mary Motyl, Seongah Han, Anjana Grandhi, Hetty Waskin
Topics & Concepts
MedicineVoriconazolePosaconazoleAspergillosisClinical endpointPopulationInternal medicineRandomized controlled trialSurgeryImmunologyAntifungalEnvironmental healthDermatologyAntifungal resistance and susceptibilityOcular Infections and TreatmentsFungal Infections and Studies